Porazzi, P., Pucillo, M., Padmanabhan, A. A., Nason, S., Zheng, Z., Paruzzo, L., Ho, M., Michener, P., Stella, F., Imparato, A., Susanibar-Adaniya, S., Garfall, A., Fraietta, J., Ruella, M. (2025). Epigenetic reprogramming via EZH1/2 inhibition enhances T cell-mediated immunotherapies against multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-2160